Corneal substitutes are being developed to address the shortage of human donor tissues as well as the current disadvantages in some clinical indications, which include immune rejection. In the past few years, there have been significant developments in bioengineered corneas that are designed to replace part or the full thickness of damaged or diseased corneas that range from keratoprostheses that solely address the replacement of the cornea's function, through tissue-engineered hydrogels that permit regeneration of host tissues. We describe examples of corneal substitutes that encourage regeneration of the host tissue. We also contend that it is unlikely that there will be a single one-size-fits-all corneal substitute for all indications. Instead, there will most likely be a small range of corneal substitutes ranging from prostheses to tissue-engineered matrix substitutes that are tailored to different clusters of clinical indications. The tissue-engineered matrices can either be produced as sterile acellular matrices, or complete with functional cells, ready for implantation. © 2009 Macmillan Publishers Limited All rights reserved.
CITATION STYLE
Griffith, M., Jackson, W. B., Lagali, N., Merrett, K., Li, F., & Fagerholm, P. (2009). Artificial corneas: A regenerative medicine approach. In Eye (Vol. 23, pp. 1985–1989). Nature Publishing Group. https://doi.org/10.1038/eye.2008.409
Mendeley helps you to discover research relevant for your work.